Huma Raises $80 Million Reaching Near-$1 Billion Valuation (1)

Huma Therapeutics Ltd. has raised $80 million, valuing the startup at nearly $1 billion in the increasingly crowded health-care AI arena.

The Series D financing for the London-headquartered firm includes investments by drug makers AstraZeneca Plc and Bayer AG, as well as Japan’s Hitachi Ventures and Italy’s Hat Technology Fund, according to Huma Chief Executive Officer Dan Vahdat.

The startup, which has raised a total of $300 million so far, doubled its annual revenue to $40 million in 2023 and aims to report a profit by year-end, he said.

Dan Vahdat

Source: Huma

“Huma is Shopify, but for digital health,” ...